Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis

por John, Binu, Doshi, Akash, Deng, Yangyang, Mansour, Natalie, Barritt, A.Sidne, Moon, Andrew, Ioannou, George, Martin, Paul, Chao, Hann-Hsiang, Taddei, Tamar H, Kaplan, David, Dahman, Bassam
Publicado 2022

Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis

por John, Binu V., Sidney Barritt, A., Moon, Andrew, Taddei, Tamar H., Kaplan, David E., Dahman, Bassam, Doshi, Akash, Deng, Yangyang, Mansour, Natalie, Ioannou, George, Martin, Paul, Chao, Hann-Hsiang
Publicado 2022

Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS

por John, Binu V., Doshi, Akash, Deng, Yangyang, Mansour, Natalie, Barritt, Alfred Sidney, Moon, Andrew M., Ioannou, George N., Martin, Paul, Chao, Hann-Hsiang, Taddei, Tamar H., Kaplan, David E., Dahman, Bassam
Publicado 2022